Other ICBs combined with TIGIT blocking can enhance the anti-tumor immune response, such that blocking TIGIT and PD-1 together can enhance the proliferation of CD8+ T cells and protect memory T cells [126]. This evidence concerns the gene CD8A and neoplasm.